Statera Biopharma Pink Sheet Forecast - Accumulation Distribution
| STAB Stock | USD 0.0003 0.0002 200.00% |
Statera Pink Sheet Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Statera Biopharma stock prices and determine the direction of Statera Biopharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Statera Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the relative strength index (rsi) of Statera Biopharma's share price is below 20 . This usually implies that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Statera Biopharma hype-based prediction, you can estimate the value of Statera Biopharma from the perspective of Statera Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
Statera Biopharma after-hype prediction price | USD 2.7E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Statera |
Statera Biopharma Additional Predictive Modules
Most predictive techniques to examine Statera price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Statera using various technical indicators. When you analyze Statera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Statera Biopharma Volatility | Backtest Statera Biopharma | Information Ratio |
Statera Biopharma Trading Date Momentum
| On January 04 2026 Statera Biopharma was traded for 0.0003 at the closing time. The top price for the day was 0.0003 and the lowest listed price was 0.0003 . There was no trading activity during the period 0.0. Lack of trading volume on January 4, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Statera Biopharma to competition |
Other Forecasting Options for Statera Biopharma
For every potential investor in Statera, whether a beginner or expert, Statera Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Statera Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Statera. Basic forecasting techniques help filter out the noise by identifying Statera Biopharma's price trends.Statera Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Statera Biopharma pink sheet to make a market-neutral strategy. Peer analysis of Statera Biopharma could also be used in its relative valuation, which is a method of valuing Statera Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Statera Biopharma Technical and Predictive Analytics
The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Statera Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Statera Biopharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Statera Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Statera Biopharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Statera Biopharma shares will generate the highest return on investment. By undertsting and applying Statera Biopharma pink sheet market strength indicators, traders can identify Statera Biopharma entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 3.0 | |||
| Day Median Price | 3.0E-4 | |||
| Day Typical Price | 3.0E-4 | |||
| Price Action Indicator | 1.0E-4 | |||
| Period Momentum Indicator | 2.0E-4 |
Statera Biopharma Risk Indicators
The analysis of Statera Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Statera Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting statera pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 29.06 | |||
| Semi Deviation | 19.28 | |||
| Standard Deviation | 49.17 | |||
| Variance | 2417.77 | |||
| Downside Variance | 3564.81 | |||
| Semi Variance | 371.66 | |||
| Expected Short fall | (116.67) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Other Information on Investing in Statera Pink Sheet
Statera Biopharma financial ratios help investors to determine whether Statera Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Statera with respect to the benefits of owning Statera Biopharma security.